Eton Pharmaceuticals Inc. (ETON)

15.06

-0.64 (-4.08%)

At close: Mar 03, 2025, 3:59 PM

15.03

-0.20%

After-hours: Mar 03, 2025, 04:00 PM EST

Eton Pharmaceuticals Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Net Income	-936K	-9.02M	-1.96M	-27.97M	-18.32M	-12.74M	-7.16M
Depreciation & Amortization	901K	1.77M	462K	651K	447K	63K	13K
Stock-Based Compensation	3.14M	4.22M	3.38M	2.58M	1.89M	1.85M	2.64M
Other Working Capital	5.46M	4.12M	-910K	-320K	-827K	-314K	84K
Other Non-Cash Items	117K	127K	148K	1.39M	16K	2.58M	1.29M
Deferred Income Tax	n/a	n/a	-546K	n/a	n/a	n/a	n/a
Change in Working Capital	3.6M	7.72M	-6.21M	1.01M	-2.06M	99K	623K
Operating Cash Flow	6.82M	4.82M	-4.72M	-22.35M	-18.03M	-8.14M	-4.72M
Capital Expenditures	-775K	-2.79M	-3.26M	-50K	-1.85M	-236K	-130K
Acquisitions	n/a	n/a	700K	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	-2.75M	-2.55M	n/a	-750K	n/a	n/a
Investing Cash Flow	-775K	-2.79M	-2.56M	-50K	-1.85M	-236K	-130K
Debt Repayment	-1.16M	-385K	-150K	2.48M	4.75M	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	-1.05M	n/a
Other Financial Acitivies	198K	251K	541K	367K	453K	205K	18M
Financial Cash Flow	-957K	-134K	391K	31.63M	5.2M	21.96M	18M
Net Cash Flow	5.08M	1.9M	-6.89M	9.23M	-14.67M	13.58M	13.16M
Free Cash Flow	6.04M	2.03M	-7.98M	-22.4M	-19.87M	-8.38M	-4.85M